Bischoff SCUniversity of Hohenheim, Institute of Nutritional Medicine, Stuttgart, Germany. Electronic address: bischoff.stephan@uni-hohenheim.de.
Austin PPharmacy Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; University College London School of Pharmacy, London, UK.
Boeykens KAZ Nikolaas Hospital, Nutrition Support Team, Sint-Niklaas, Belgium.
Chourdakis MSchool of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Cuerda CHospital General Universitario Gregorio Marañón, Nutrition Unit, Madrid, Spain.
Jonkers-Schuitema CAmsterdam University Medical Center Location AMC, Amsterdam, the Netherlands.
Lichota MIntestinal Failure Patients Association "Appetite for Life", Cracow, Poland.
Nyulasi IDepartment of Nutrition, Department of Rehabilitation, Nutrition and Sport, Latrobe University; Department of Medicine, Monash University, Australia.
Schneider SMGastroenterology and Nutrition, Centre Hospitalier Universitaire, Université Côte d'Azur, Nice, France.
Stanga ZDivision of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital and University of Bern, Switzerland.
Pironi LCenter for Chronic Intestinal Failure, St. Orsola-Malpighi University Hospital, Bologna, Italy.
English
This guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other home enteral nutrition (HEN) providers about the indications and contraindications for HEN, and its implementation and monitoring. Home parenteral nutrition is not included but will be addressed in a separate ESPEN guideline. This guideline will also inform interested patients requiring HEN. The guideline is based on current evidence and expert opinion and consists of 61 recommendations that address the indications for HEN, relevant access devices and their use, the products recommended, the monitoring and criteria for termination of HEN, and the structural requirements needed to perform HEN. We searched for meta-analyses, systematic reviews and single clinical trials based on clinical questions according to the PICO format. The evidence was evaluated and used to develop clinical recommendations implementing the SIGN method. The guideline was commissioned and financially supported by ESPEN and the members of the guideline group were selected by ESPEN.